270 institutions reported holding ANIP for 2026Q1, together 106% of the company, fewer than the 281 a quarter earlier. Institutions reporting a position: 270 (as of 2026Q1). Shares held by institutions: 22.9M, long US equity positions only, as reported on Form 13F. Reported value: $1.76B, at 2026-03-31 prices, not today's. Top 5 holders: 30%, of the whole company, between five filers.

ANIPANI Pharmaceuticals, Inc.

HealthcareUSD

$74.57

$70.4952 weeks$98.81

Who owns ANIP

270 institutions reported holding ANIP for 2026Q1, together 106% of the company, fewer than the 281 a quarter earlier.

270

Institutions reporting a position · as of 2026Q1 · down from 281 the quarter before

Shares held by institutions: 22.9M
Shares held by institutions · 106% of the company · long US equity positions only, as reported on Form 13F
Reported value: $1.76B
Reported value · at 2026-03-31 prices, not today's
Top 5 holders: 30%
Top 5 holders · of the whole company, between five filers

Details›

Reporting quarter2026-03-31: 2026Q1
Quarters on record: 52
New positions: 36
Positions exited: 52
Added to: 99
Reduced: 78
Top 10 holdersof the company: 43%

Institutional ownership by quarter, 2013Q2 to 2026Q1
Quarter	Filers	Shares	Reported value
2026Q1	270	22.9M	$1.76B
2025Q4	281	21.2M	$1.67B
2025Q3	263	20.3M	$1.86B
2025Q2	227	19.6M	$1.28B
2025Q1	226	20.0M	$1.35B
2024Q4	202	19.3M	$1.07B
2024Q3	206	18.9M	$1.14B
2024Q2	200	15.1M	$962M
2024Q1	198	14.1M	$975M
2023Q4	182	13.6M	$751M
2023Q3	185	13.2M	$766M
2023Q2	171	12.2M	$658M
2023Q1	137	10.3M	$408M
2022Q4	124	10.2M	$409M
2022Q3	124	10.2M	$328M
2022Q2	119	9.8M	$291M

Largest reported holders, 2026Q1
Holder	Shares	% of company	Value
BlackRock Inc.	2.7M	13%	$211M
VANGUARD GROUP INC	1.3M	6.3%	$104M
Soleus Capital Management, L.P.	0.8M	3.8%	$63M
STATE STREET CORP	0.8M	3.6%	$59M
TANG CAPITAL MANAGEMENT LLC	0.7M	3.3%	$54M
GOLDENTREE ASSET MANAGEMENT LP	0.7M	3.1%	$51M
Deep Track Capital, LP	0.6M	2.8%	$46M
MILLENNIUM MANAGEMENT LLC	0.6M	2.7%	$46M
ARROWSTREET CAPITAL LIMITED PARTNERSHIP	0.6M	2.6%	$43M
DIMENSIONAL FUND ADVISORS LP	0.5M	2.5%	$41M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…

Drug Manufacturers - Specialty & Generic

Ranks #10 of 28 by Smart Score

Compare peers

AMLX+2.6%

Amylyx Pharmaceuticals, Inc.

BHC+5.8%

Bausch Health Companies Inc.

HCM+0.19%

HUTCHMED (China) Limited

PBH-0.30%

Prestige Consumer Healthcare Inc.

HROW-2.8%

Harrow, Inc.

BCRX-1.0%

BioCryst Pharmaceuticals, Inc.